Literature DB >> 25241376

First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids.

Mathieu Luyckx1, Jean-Luc Squifflet2, Pascale Jadoul2, Rafaella Votino2, Marie-Madeleine Dolmans3, Jacques Donnez4.   

Abstract

OBJECTIVE: To study the pregnancy rate after ulipristal acetate (UPA) therapy for fibroids.
DESIGN: Retrospective analysis of a series of 52 patients prospectively included in the PGL4001 (ulipristal acetate) Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARL) II and III trials.
SETTING: Academic hospital. PATIENT(S): Among the 52 patients, 21 wished to conceive upon treatment completion. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Pregnancy rate and live birth rate. RESULT(S): Twenty-one patients attempted to get pregnant, among whom 15 (71%) succeeded, totaling 18 pregnancies. Among these 18 pregnancies, 12 resulted in the birth of 13 healthy babies and 6 ended in early miscarriage. No regrowth of fibroids was observed during pregnancy. CONCLUSION(S): We report the first series of pregnancies achieved after UPA treatment. Our data confirm a sustained long-term effect after UPA therapy.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fibroids; pregnancy; selective progesterone receptor modulators (SPRMs); ulipristal acetate

Mesh:

Substances:

Year:  2014        PMID: 25241376     DOI: 10.1016/j.fertnstert.2014.07.1253

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  18 in total

1.  Medical Management of Symptomatic Fibroids: Worth It?

Authors:  Chandrashekhar V Hegde
Journal:  J Obstet Gynaecol India       Date:  2017-06-10

Review 2.  Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma.

Authors:  Anusha Shreenidhi Bhat; Ningthoujam Anirudh Singh; Emdormi Rymbai; Swapna Birendra; Saravanan Jayaram; Divakar Selvaraj
Journal:  Reprod Sci       Date:  2022-08-15       Impact factor: 2.924

Review 3.  Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids.

Authors:  Karly P Garnock-Jones; Sean T Duggan
Journal:  Drugs       Date:  2017-10       Impact factor: 9.546

Review 4.  Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence.

Authors:  Alice Trefoux Bourdet; Dominique Luton; Martin Koskas
Journal:  Int J Womens Health       Date:  2015-03-26

5.  Ulipristal Acetate in Myomectomy Optimization in an Infertile Patient with Giant Myomas.

Authors:  Elena de la Fuente; María Dolores Borrás; Miriam Rubio; Nuria Abril
Journal:  Case Rep Med       Date:  2016-08-10

Review 6.  Uterine fibroids - what's new?

Authors:  Alistair R W Williams
Journal:  F1000Res       Date:  2017-12-07

Review 7.  The Rising Phoenix-Progesterone as the Main Target of the Medical Therapy for Leiomyoma.

Authors:  H H Chill; M Safrai; A Reuveni Salzman; A Shushan
Journal:  Biomed Res Int       Date:  2017-09-13       Impact factor: 3.411

Review 8.  Recent scientific advances in leiomyoma (uterine fibroids) research facilitates better understanding and management.

Authors:  Darlene K Taylor; Kristine Holthouser; James H Segars; Phyllis C Leppert
Journal:  F1000Res       Date:  2015-07-06

Review 9.  Fibroids and Infertility.

Authors:  P Purohit; K Vigneswaran
Journal:  Curr Obstet Gynecol Rep       Date:  2016-04-25

Review 10.  Uterine fibroid management: from the present to the future.

Authors:  Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Hum Reprod Update       Date:  2016-07-27       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.